Session » (2195–2226) Reproductive Issues in Rheumatic Disorders Posters

10:30AM-12:30PM

Abstract Number: 2204

A Novel Framework for Teratogenicity Counseling for Adolescents and Young Adults (AYAs) with Rheumatic Disease on Teratogenic Medications

10:30AM-12:30PM

Abstract Number: 2201

Adherence to Reproductive Health Guidelines in Lupus Care: Insights from Patient and Physician Surveys

10:30AM-12:30PM

Abstract Number: 2206

Adolescents with Systemic Lupus Erythematosus at Highest Risk of Adverse Pregnancy Outcomes

10:30AM-12:30PM

Abstract Number: 2213

Awareness Regarding Contraceptive Measures, Drug Usage And Factors Affecting Pregnancy Among Patients With Autoimmune Rheumatic Diseases

10:30AM-12:30PM

Abstract Number: 2210

Changes in Treatment Pathways Over Time in Pregnancies with Active Lupus Nephritis

10:30AM-12:30PM

Abstract Number: 2208

Contraception and Pregnancy Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis

10:30AM-12:30PM

Abstract Number: 2199

Disparities in Reproductive Health Counseling Among Hispanic Women with Autoimmune Rheumatic Diseases: Insights from a Patient-Reported Survey in an Urban Safety-Net Setting

10:30AM-12:30PM

Abstract Number: 2205

Effectiveness of Reproductive Health Counseling for Rheumatology Patients

10:30AM-12:30PM

Abstract Number: 2195

Enhancing MTX and LEF Safety for Immunosuppressed Women of Childbearing Age with Rheumatic Diseases

10:30AM-12:30PM

Abstract Number: 2202

Epidemiologic Evaluation of Postpartum Mental Health for Women Living with Systemic Lupus Erythematosus: A Population-Based Cohort Study Among Medicaid Enrollees

10:30AM-12:30PM

Abstract Number: 2216

Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific Factors

10:30AM-12:30PM

Abstract Number: 2226

Factors Associated with Contraceptive Counseling by Rheumatologists for Reproductive-Aged Female Patients Prescribed Teratogenic Medications

10:30AM-12:30PM

Abstract Number: 2224

Failure of Steroid and Antimalarial Therapy to Normalize Placental Interferon and Angiogenic Gene Expression in SLE

10:30AM-12:30PM

Abstract Number: 2220

Human Milk Fatty Acid Profiles Among Breastfeeding Mothers With and Without Systemic Autoimmune Rheumatic Diseases

10:30AM-12:30PM

Abstract Number: 2214

Hydroxychloroquine and Pregnancy Outcomes in Lupus: Results from a population-based cohort study

10:30AM-12:30PM

Abstract Number: 2212

Impact of the 2020 ACR Reproductive Health Guidelines on Treatment Strategies and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Single-Center Retrospective Study

10:30AM-12:30PM

Abstract Number: 2223

Improving collaboration between rheumatology and OBGYN in the reproductive health care of patients with rheumatic disease

10:30AM-12:30PM

Abstract Number: 2217

Improving Patient Counseling on Medication Safety During Reproductive Years

10:30AM-12:30PM

Abstract Number: 2211

Maternal Adverse Pregnancy Outcomes and Risk Factors in Patients with Systemic Lupus Erythematosus in the United States

10:30AM-12:30PM

Abstract Number: 2203

Maternal and Fetal Outcomes Associated with IL-17 Inhibitor Exposure During Pregnancy in Patients with Seronegative Arthritis: A Case Series of Nine

10:30AM-12:30PM

Abstract Number: 2197

Mechanisms of Fetal Growth Restriction in Rheumatologic Autoimmune Diseases: Insights into Placental Pathology and Immune Dysregulation

10:30AM-12:30PM

Abstract Number: 2207

Menopause Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis

10:30AM-12:30PM

Abstract Number: 2222

Neonatal Myocardial Strain in Offspring born to Mothers with Systemic Lupus Erythematosus: Pilot Data from the LEGACY Cohort

10:30AM-12:30PM

Abstract Number: 2200

Obstetric and Neonatal Complications in Women living with Axial Spondyloarthritis: a population-based, matched cohort study

10:30AM-12:30PM

Abstract Number: 2215

Placenta Abnormalities in Systemic Lupus Erythematosus: Novel Marker of Adverse Pregnancy Outcomes

10:30AM-12:30PM

Abstract Number: 2218

Pregnancy Outcomes and Placental Findings in Women with IgA Vasculitis: A Case-Control Study

10:30AM-12:30PM

Abstract Number: 2209

Pregnancy outcomes in Systemic Lupus Erythematosus: Insights from a multicenter Spanish Study on the impact of antiphospholipid antibodies and APS

10:30AM-12:30PM

Abstract Number: 2221

Racial Differences in Cardiovascular Events and Adverse Pregnancy Outcomes Among Pregnant Individuals With Systemic Lupus Erythematosus

10:30AM-12:30PM

Abstract Number: 2196

Recognition and Treatment of Idiopathic Granulomatous Mastitis: A Case Series

10:30AM-12:30PM

Abstract Number: 2198

Sociocultural Influences on Pregnancy Planning for Individuals Diagnosed with SLE in an Urban Hispanic Population: A Qualitative Study with Considerations for a Holistic Approach

10:30AM-12:30PM

Abstract Number: 2225

The Impact of Pregnancy Planning on the Prevalence of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Retrospective Study from Three Japanese Tertiary Referral Centers

10:30AM-12:30PM

Abstract Number: 2219

Transcriptomic and Immune Landscape of Recurrent Pregnancy Loss and Unexplained Infertility in Systemic Lupus Erythematosus